Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperlipidemias | 3 | 2023 | 773 | 1.320 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2297 | 1.120 |
Why?
|
Antihypertensive Agents | 5 | 2022 | 2026 | 1.070 |
Why?
|
Hypertension | 8 | 2023 | 8615 | 1.000 |
Why?
|
Glycosides | 1 | 2024 | 100 | 0.890 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2024 | 12252 | 0.800 |
Why?
|
Eligibility Determination | 2 | 2022 | 421 | 0.780 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 5892 | 0.750 |
Why?
|
Cardiovascular Diseases | 7 | 2024 | 15662 | 0.720 |
Why?
|
Incretins | 1 | 2021 | 100 | 0.710 |
Why?
|
Medicare Part C | 2 | 2022 | 332 | 0.690 |
Why?
|
Glucagon-Like Peptides | 1 | 2021 | 157 | 0.680 |
Why?
|
Rural Health | 1 | 2021 | 300 | 0.650 |
Why?
|
Blood Pressure | 5 | 2022 | 8541 | 0.650 |
Why?
|
Economics, Hospital | 1 | 2021 | 210 | 0.630 |
Why?
|
Urban Health | 1 | 2021 | 535 | 0.610 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3253 | 0.600 |
Why?
|
Anti-Obesity Agents | 1 | 2021 | 240 | 0.590 |
Why?
|
Heart Failure | 7 | 2024 | 11879 | 0.560 |
Why?
|
Nutrition Surveys | 7 | 2024 | 1738 | 0.550 |
Why?
|
Exercise Test | 1 | 2024 | 2187 | 0.530 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1672 | 0.530 |
Why?
|
United States | 26 | 2024 | 73180 | 0.510 |
Why?
|
Prevalence | 10 | 2024 | 15875 | 0.500 |
Why?
|
Glomerular Filtration Rate | 3 | 2024 | 2228 | 0.480 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5176 | 0.480 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1243 | 0.460 |
Why?
|
Drug Approval | 1 | 2021 | 820 | 0.460 |
Why?
|
Secondary Prevention | 1 | 2020 | 1476 | 0.440 |
Why?
|
Diabetes Complications | 1 | 2020 | 1320 | 0.440 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2402 | 0.440 |
Why?
|
Myocardial Ischemia | 1 | 2024 | 2139 | 0.440 |
Why?
|
Kidney Diseases | 1 | 2023 | 2100 | 0.410 |
Why?
|
Lipids | 1 | 2022 | 3345 | 0.370 |
Why?
|
Medicare | 4 | 2022 | 6888 | 0.350 |
Why?
|
Health Status Disparities | 1 | 2021 | 1886 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3447 | 0.320 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3421 | 0.310 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1669 | 0.300 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2763 | 0.300 |
Why?
|
Hospital Mortality | 1 | 2021 | 5369 | 0.280 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6569 | 0.270 |
Why?
|
Humans | 46 | 2024 | 768887 | 0.270 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26384 | 0.250 |
Why?
|
Obesity | 4 | 2023 | 13087 | 0.230 |
Why?
|
Male | 22 | 2024 | 365249 | 0.210 |
Why?
|
Middle Aged | 17 | 2024 | 223740 | 0.200 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2022 | 69 | 0.200 |
Why?
|
Adult | 15 | 2024 | 223818 | 0.190 |
Why?
|
Female | 22 | 2024 | 397464 | 0.190 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3110 | 0.190 |
Why?
|
Cause of Death | 3 | 2024 | 3721 | 0.190 |
Why?
|
Registries | 1 | 2018 | 8384 | 0.190 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5520 | 0.190 |
Why?
|
Aged | 18 | 2024 | 171790 | 0.180 |
Why?
|
Colchicine | 1 | 2021 | 257 | 0.170 |
Why?
|
Risk Factors | 8 | 2024 | 74971 | 0.170 |
Why?
|
Hospitals, Rural | 1 | 2021 | 176 | 0.170 |
Why?
|
Hospitals, Urban | 1 | 2021 | 499 | 0.160 |
Why?
|
Health Expenditures | 2 | 2022 | 2396 | 0.160 |
Why?
|
Hypotension, Orthostatic | 1 | 2022 | 258 | 0.160 |
Why?
|
Drug Labeling | 1 | 2021 | 250 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10397 | 0.160 |
Why?
|
Health Services Misuse | 1 | 2020 | 249 | 0.150 |
Why?
|
Time Factors | 6 | 2024 | 40266 | 0.150 |
Why?
|
Anticoagulants | 2 | 2024 | 4850 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2022 | 365 | 0.150 |
Why?
|
Hospital Administration | 1 | 2021 | 353 | 0.140 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1820 | 0.140 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1157 | 0.130 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 1026 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1568 | 0.130 |
Why?
|
Neuromuscular Diseases | 1 | 2019 | 261 | 0.130 |
Why?
|
Reimbursement, Incentive | 1 | 2021 | 549 | 0.130 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2019 | 261 | 0.130 |
Why?
|
Warfarin | 1 | 2024 | 1493 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2018 | 594 | 0.120 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3941 | 0.120 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 973 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1216 | 0.120 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2024 | 1252 | 0.120 |
Why?
|
Patients | 1 | 2021 | 908 | 0.120 |
Why?
|
Reference Standards | 1 | 2018 | 1014 | 0.110 |
Why?
|
Drug Utilization | 1 | 2020 | 1191 | 0.110 |
Why?
|
Needs Assessment | 1 | 2020 | 1142 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 646 | 0.110 |
Why?
|
Cholesterol | 1 | 2022 | 2913 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1407 | 0.110 |
Why?
|
Inpatients | 1 | 2024 | 2570 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2018 | 2931 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2024 | 65485 | 0.090 |
Why?
|
Cardiology | 1 | 2022 | 1701 | 0.090 |
Why?
|
Databases, Factual | 3 | 2024 | 8095 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2915 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 3069 | 0.080 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1106 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 8055 | 0.080 |
Why?
|
Insulin | 1 | 2022 | 6610 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 30044 | 0.070 |
Why?
|
Public Health | 1 | 2021 | 2680 | 0.070 |
Why?
|
Patient Readmission | 1 | 2022 | 3313 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1880 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1962 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2598 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2518 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 4053 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2194 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12873 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18454 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 41800 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 13054 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10641 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12563 | 0.050 |
Why?
|
Comorbidity | 1 | 2018 | 10591 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39394 | 0.050 |
Why?
|
Naphthyridines | 1 | 2022 | 185 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4607 | 0.040 |
Why?
|
Sex Distribution | 1 | 2024 | 2280 | 0.040 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2019 | 64 | 0.040 |
Why?
|
Age Distribution | 1 | 2024 | 2875 | 0.040 |
Why?
|
Stroke Volume | 2 | 2023 | 5621 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 487 | 0.040 |
Why?
|
Young Adult | 2 | 2023 | 60110 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3903 | 0.040 |
Why?
|
Albuminuria | 1 | 2022 | 658 | 0.040 |
Why?
|
Risk | 2 | 2021 | 9621 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1051 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 14199 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11521 | 0.030 |
Why?
|
Patient Care | 1 | 2022 | 629 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 24330 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9756 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2088 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1064 | 0.030 |
Why?
|
Aftercare | 1 | 2020 | 921 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1369 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1645 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13677 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6085 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 936 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2724 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3629 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7245 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6346 | 0.020 |
Why?
|
Hemorrhage | 1 | 2020 | 3465 | 0.020 |
Why?
|
Medicaid | 1 | 2022 | 2843 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59738 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9384 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3490 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9682 | 0.020 |
Why?
|
Incidence | 1 | 2021 | 21545 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13317 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 81892 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16735 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2018 | 4879 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10845 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26394 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36541 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42684 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30266 | 0.010 |
Why?
|
Child | 1 | 2019 | 80969 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89247 | 0.010 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_